Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says
googletag.cmd.push(function() googletag.display('maavaron.ros.ctech');
googletag.pubads().addEventListener('slotRenderEnded', function(event)
if (event.slot.getSlotElementId() == 'maavaron.ros.ctech')
if (event.isEmpty)
document.getElementById('maavaron.ros.ctech').style.display = 'none';
);
);
try
if (maavaronshow==0)
console.log("maavaron hidden" + localStorage.maavaronView);
$('#siteOverlay').hide();
catch(err)
$('#siteOverlay').hide();
googletag.pubads().addEventListener('slotRenderEnded', function(event)
if (event.slot.getSlotElementId() == 'maavaron.ros.ctech')
if (event.isEmpty)
document.getElementById('maavaron.ros.ctech').style.display = 'none';
);
);
try
if (maavaronshow==0)
console.log("maavaron hidden" + localStorage.maavaronView);
$('#siteOverlay').hide();
catch(err)
$('#siteOverlay').hide();
- About
- Buzz
- Startups
- 24/7
Newsletter
by
| ||
@media all and (max-width: 1240px)
.TrajectoryTable width: 550px;
div.header-user-profile width: 890px;
.art-trajectory .TrajectoryTable width: 890px;overflow: hidden;margin-right: 57px;
$(document).ready(function()
if (navigator.appName == 'Microsoft Internet Explorer')
$('.trajectoryTextf').removeClass('OpenSansRegular');
);
function openWin(url,title,attrib) wref=window.open(url,title,attrib);if(MSIE_VER()>=5)wref.focus()
function openInnewWindow(url,width,height,toolbar)
if(toolbar==1)
openWin(url,'Calcalist','toolbar=yes,location=yes,directories=yes,status=yes,menubar=yes,scrollbars=yes,resizable=yes,width='+width+',height='+height)
else
openWin(url,'Calcalist','toolbar=no,location=no,directories=no,status=yes,menubar=no,scrollbars=no,movable=yes,resizable=yes,width='+width+',height='+height)
googletag.cmd.push(function() googletag.display('prime.ctech'); );
Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says
The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month
12:0226.08.18
Earlier this month, the U.S. Food and Drug Administration awarded Teva Pharmaceutical Industries Ltd. approval to market the first generic version of Mylan NV’s EpiPen auto-injectors. But now, amidst product shortages, SunTrust Robinson Humphrey analyst John Boris says Teva’s EpiPen—the price of which has yet to be announced—will not hit the market in time for the start of the school year.
For daily updates, subscribe to our newsletter by clicking here.
Cited in a Friday report by MarketWatch, Boris said that wholesalers expect at least two months of waiting before Teva’s generic version could be found on the shelves. In the U.S., the first day of school usually falls after Labor Day, on the first Monday of September, but some districts open in August. Deficiencies in the market could hinder both schools and parents looking to stock up.
Students. Photo: Shutterstock googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );
Last week, Mylan announced extended expiration dates for some EpiPen batches in coordination with the FDA, to prepare for growing demand ahead of the school year. Mylan also stated it expects supply to stabilize in the fourth quarter of 2018.
jQuery(document).ready( function()
jQuery('.ArticlePromotionMor').click(function()
GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
);
);
Related stories:
- Teva Wins FDA Approval for First Generic EpiPen
- Berkshire Hathaway Builds Teva Position for Third Quarter in a Row
- Teva's American Dream Boat is Sinking
googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );
Teva was down 3.28% on NYSE on Friday market close.
googletag.cmd.push(function() googletag.display('strip.ros.ctech'); );
Cancel
Send
To all comments
Buzz
10 Israeli Startups that Are Looking For U.S. Investments
Chinese Online Fashion Retailer MyMM to Implement Image Search 
Agritech Drone Startup Aerodrome Monitors Crops From the Sky 
Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding 
AI Cancer Detection Startup Nucleai Raises $5 Million 
Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz googletag.cmd.push(function() googletag.display('big.box1.ros.ctech'); );
Recently Read
Saar Wilf’s Bid to Rid the World of Clunky Online Payments 
Calcalist’s 2018 List of 50 Most Promising Israeli Startups 
Hit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts googletag.cmd.push(function() googletag.display('sopranos.1.ros.ctech'); );
Recommended videos
Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car Agritech Drone Startup Aerodrome Monitors Crops From the Sky googletag.cmd.push(function() googletag.display('big.box2.ros.ctech'); );
googletag.cmd.push(function() googletag.display('special.prime.ros.ctech'); );
Twitter
Facebook
Newsletter
Contact Us
Rss
About CTech
Terms of Use
Privacy Policy
Developed by
UI & UX by Basch_Interactive
var axel = Math.random() + '';
var a = axel * 10000000000000;
document.write('
if (window.location.href.toLowerCase().indexOf('lobby')>-1)
document.querySelector('*[id^="prime."]').parentElement.removeChild(document.querySelector('*[id^="prime."]'));
document.getElementById('vilon').parentElement.removeChild(document.getElementById('vilon'));
document.getElementById('siteOverlay').parentElement.removeChild(document.getElementById('siteOverlay'));
- About
- Buzz
- Startups
- 24/7
Newsletter
by
| ||
@media all and (max-width: 1240px)
.TrajectoryTable width: 550px;
div.header-user-profile width: 890px;
.art-trajectory .TrajectoryTable width: 890px;overflow: hidden;margin-right: 57px;
$(document).ready(function()
if (navigator.appName == 'Microsoft Internet Explorer')
$('.trajectoryTextf').removeClass('OpenSansRegular');
);
function openWin(url,title,attrib) wref=window.open(url,title,attrib);if(MSIE_VER()>=5)wref.focus()
function openInnewWindow(url,width,height,toolbar)
if(toolbar==1)
openWin(url,'Calcalist','toolbar=yes,location=yes,directories=yes,status=yes,menubar=yes,scrollbars=yes,resizable=yes,width='+width+',height='+height)
else
openWin(url,'Calcalist','toolbar=no,location=no,directories=no,status=yes,menubar=no,scrollbars=no,movable=yes,resizable=yes,width='+width+',height='+height)
- About
- Buzz
- Startups
- 24/7
Newsletter
by
| ||
@media all and (max-width: 1240px)
.TrajectoryTable width: 550px;
div.header-user-profile width: 890px;
.art-trajectory .TrajectoryTable width: 890px;overflow: hidden;margin-right: 57px;
$(document).ready(function()
if (navigator.appName == 'Microsoft Internet Explorer')
$('.trajectoryTextf').removeClass('OpenSansRegular');
);
function openWin(url,title,attrib) wref=window.open(url,title,attrib);if(MSIE_VER()>=5)wref.focus()
function openInnewWindow(url,width,height,toolbar)
if(toolbar==1)
openWin(url,'Calcalist','toolbar=yes,location=yes,directories=yes,status=yes,menubar=yes,scrollbars=yes,resizable=yes,width='+width+',height='+height)
else
openWin(url,'Calcalist','toolbar=no,location=no,directories=no,status=yes,menubar=no,scrollbars=no,movable=yes,resizable=yes,width='+width+',height='+height)
by
| ||
@media all and (max-width: 1240px)
.TrajectoryTable width: 550px;
div.header-user-profile width: 890px;
.art-trajectory .TrajectoryTable width: 890px;overflow: hidden;margin-right: 57px;
$(document).ready(function()
if (navigator.appName == 'Microsoft Internet Explorer')
$('.trajectoryTextf').removeClass('OpenSansRegular');
);
function openWin(url,title,attrib) wref=window.open(url,title,attrib);if(MSIE_VER()>=5)wref.focus()
function openInnewWindow(url,width,height,toolbar)
if(toolbar==1)
openWin(url,'Calcalist','toolbar=yes,location=yes,directories=yes,status=yes,menubar=yes,scrollbars=yes,resizable=yes,width='+width+',height='+height)
else
openWin(url,'Calcalist','toolbar=no,location=no,directories=no,status=yes,menubar=no,scrollbars=no,movable=yes,resizable=yes,width='+width+',height='+height)
by
| ||
@media all and (max-width: 1240px)
.TrajectoryTable width: 550px;
div.header-user-profile width: 890px;
.art-trajectory .TrajectoryTable width: 890px;overflow: hidden;margin-right: 57px;
$(document).ready(function()
if (navigator.appName == 'Microsoft Internet Explorer')
$('.trajectoryTextf').removeClass('OpenSansRegular');
);
function openWin(url,title,attrib) wref=window.open(url,title,attrib);if(MSIE_VER()>=5)wref.focus()
function openInnewWindow(url,width,height,toolbar)
if(toolbar==1)
openWin(url,'Calcalist','toolbar=yes,location=yes,directories=yes,status=yes,menubar=yes,scrollbars=yes,resizable=yes,width='+width+',height='+height)
else
openWin(url,'Calcalist','toolbar=no,location=no,directories=no,status=yes,menubar=no,scrollbars=no,movable=yes,resizable=yes,width='+width+',height='+height)
- Homepage
- News
googletag.cmd.push(function() googletag.display('prime.ctech'); );
googletag.cmd.push(function() googletag.display('prime.ctech'); );
googletag.cmd.push(function() googletag.display('prime.ctech'); );
Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says
The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month
12:0226.08.18
Earlier this month, the U.S. Food and Drug Administration awarded Teva Pharmaceutical Industries Ltd. approval to market the first generic version of Mylan NV’s EpiPen auto-injectors. But now, amidst product shortages, SunTrust Robinson Humphrey analyst John Boris says Teva’s EpiPen—the price of which has yet to be announced—will not hit the market in time for the start of the school year.
For daily updates, subscribe to our newsletter by clicking here.
Cited in a Friday report by MarketWatch, Boris said that wholesalers expect at least two months of waiting before Teva’s generic version could be found on the shelves. In the U.S., the first day of school usually falls after Labor Day, on the first Monday of September, but some districts open in August. Deficiencies in the market could hinder both schools and parents looking to stock up.
Students. Photo: Shutterstock googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );
Last week, Mylan announced extended expiration dates for some EpiPen batches in coordination with the FDA, to prepare for growing demand ahead of the school year. Mylan also stated it expects supply to stabilize in the fourth quarter of 2018.
jQuery(document).ready( function()
jQuery('.ArticlePromotionMor').click(function()
GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
);
);
Related stories:
- Teva Wins FDA Approval for First Generic EpiPen
- Berkshire Hathaway Builds Teva Position for Third Quarter in a Row
- Teva's American Dream Boat is Sinking
googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );
Teva was down 3.28% on NYSE on Friday market close.
googletag.cmd.push(function() googletag.display('strip.ros.ctech'); );
Cancel
Send
To all comments
Buzz
10 Israeli Startups that Are Looking For U.S. Investments
Chinese Online Fashion Retailer MyMM to Implement Image Search Agritech Drone Startup Aerodrome Monitors Crops From the Sky Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding AI Cancer Detection Startup Nucleai Raises $5 Million Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz googletag.cmd.push(function() googletag.display('big.box1.ros.ctech'); );
Recently Read
Saar Wilf’s Bid to Rid the World of Clunky Online Payments Calcalist’s 2018 List of 50 Most Promising Israeli Startups Hit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts googletag.cmd.push(function() googletag.display('sopranos.1.ros.ctech'); );
Recommended videos
Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car Agritech Drone Startup Aerodrome Monitors Crops From the Sky googletag.cmd.push(function() googletag.display('big.box2.ros.ctech'); );
Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says
The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month
12:0226.08.18
Earlier this month, the U.S. Food and Drug Administration awarded Teva Pharmaceutical Industries Ltd. approval to market the first generic version of Mylan NV’s EpiPen auto-injectors. But now, amidst product shortages, SunTrust Robinson Humphrey analyst John Boris says Teva’s EpiPen—the price of which has yet to be announced—will not hit the market in time for the start of the school year.
For daily updates, subscribe to our newsletter by clicking here.
Cited in a Friday report by MarketWatch, Boris said that wholesalers expect at least two months of waiting before Teva’s generic version could be found on the shelves. In the U.S., the first day of school usually falls after Labor Day, on the first Monday of September, but some districts open in August. Deficiencies in the market could hinder both schools and parents looking to stock up.
Students. Photo: Shutterstock googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );
Last week, Mylan announced extended expiration dates for some EpiPen batches in coordination with the FDA, to prepare for growing demand ahead of the school year. Mylan also stated it expects supply to stabilize in the fourth quarter of 2018.
jQuery(document).ready( function()
jQuery('.ArticlePromotionMor').click(function()
GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
);
);
Related stories:
- Teva Wins FDA Approval for First Generic EpiPen
- Berkshire Hathaway Builds Teva Position for Third Quarter in a Row
- Teva's American Dream Boat is Sinking
googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );
Teva was down 3.28% on NYSE on Friday market close.
Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says
The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month
12:0226.08.18
Earlier this month, the U.S. Food and Drug Administration awarded Teva Pharmaceutical Industries Ltd. approval to market the first generic version of Mylan NV’s EpiPen auto-injectors. But now, amidst product shortages, SunTrust Robinson Humphrey analyst John Boris says Teva’s EpiPen—the price of which has yet to be announced—will not hit the market in time for the start of the school year.
For daily updates, subscribe to our newsletter by clicking here.
Cited in a Friday report by MarketWatch, Boris said that wholesalers expect at least two months of waiting before Teva’s generic version could be found on the shelves. In the U.S., the first day of school usually falls after Labor Day, on the first Monday of September, but some districts open in August. Deficiencies in the market could hinder both schools and parents looking to stock up.
Students. Photo: Shutterstock googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );
Last week, Mylan announced extended expiration dates for some EpiPen batches in coordination with the FDA, to prepare for growing demand ahead of the school year. Mylan also stated it expects supply to stabilize in the fourth quarter of 2018.
jQuery(document).ready( function()
jQuery('.ArticlePromotionMor').click(function()
GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
);
);
Related stories:
- Teva Wins FDA Approval for First Generic EpiPen
- Berkshire Hathaway Builds Teva Position for Third Quarter in a Row
- Teva's American Dream Boat is Sinking
googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );
Teva was down 3.28% on NYSE on Friday market close.
12:0226.08.18
Earlier this month, the U.S. Food and Drug Administration awarded Teva Pharmaceutical Industries Ltd. approval to market the first generic version of Mylan NV’s EpiPen auto-injectors. But now, amidst product shortages, SunTrust Robinson Humphrey analyst John Boris says Teva’s EpiPen—the price of which has yet to be announced—will not hit the market in time for the start of the school year.
For daily updates, subscribe to our newsletter by clicking here.
Cited in a Friday report by MarketWatch, Boris said that wholesalers expect at least two months of waiting before Teva’s generic version could be found on the shelves. In the U.S., the first day of school usually falls after Labor Day, on the first Monday of September, but some districts open in August. Deficiencies in the market could hinder both schools and parents looking to stock up.
Students. Photo: Shutterstock googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );
Last week, Mylan announced extended expiration dates for some EpiPen batches in coordination with the FDA, to prepare for growing demand ahead of the school year. Mylan also stated it expects supply to stabilize in the fourth quarter of 2018.
jQuery(document).ready( function()
jQuery('.ArticlePromotionMor').click(function()
GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
);
);
Related stories:
- Teva Wins FDA Approval for First Generic EpiPen
- Berkshire Hathaway Builds Teva Position for Third Quarter in a Row
- Teva's American Dream Boat is Sinking
googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );
Teva was down 3.28% on NYSE on Friday market close.
Students. Photo: Shutterstock googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );
Students. Photo: Shutterstock Students. Photo: Shutterstock googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );
googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );
jQuery(document).ready( function()
jQuery('.ArticlePromotionMor').click(function()
GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
);
);
Related stories:
- Teva Wins FDA Approval for First Generic EpiPen
- Berkshire Hathaway Builds Teva Position for Third Quarter in a Row
- Teva's American Dream Boat is Sinking
googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );
Related stories:
googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );
googletag.cmd.push(function() googletag.display('strip.ros.ctech'); );
googletag.cmd.push(function() googletag.display('strip.ros.ctech'); );
Cancel
Send
To all comments
Cancel
Send
To all comments
Cancel
Send
To all comments
Cancel
Send
Cancel
Send
To all comments
To all comments
Buzz
10 Israeli Startups that Are Looking For U.S. Investments
Chinese Online Fashion Retailer MyMM to Implement Image Search Agritech Drone Startup Aerodrome Monitors Crops From the Sky Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding AI Cancer Detection Startup Nucleai Raises $5 Million Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz Buzz
10 Israeli Startups that Are Looking For U.S. Investments
Chinese Online Fashion Retailer MyMM to Implement Image Search Agritech Drone Startup Aerodrome Monitors Crops From the Sky Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding AI Cancer Detection Startup Nucleai Raises $5 Million Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz Buzz
10 Israeli Startups that Are Looking For U.S. Investments
10 Israeli Startups that Are Looking For U.S. Investments
10 Israeli Startups that Are Looking For U.S. Investments
Chinese Online Fashion Retailer MyMM to Implement Image Search Agritech Drone Startup Aerodrome Monitors Crops From the Sky Chinese Online Fashion Retailer MyMM to Implement Image Search Agritech Drone Startup Aerodrome Monitors Crops From the Sky Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding AI Cancer Detection Startup Nucleai Raises $5 Million Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding AI Cancer Detection Startup Nucleai Raises $5 Million Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz googletag.cmd.push(function() googletag.display('big.box1.ros.ctech'); );
Recently Read
Saar Wilf’s Bid to Rid the World of Clunky Online Payments Calcalist’s 2018 List of 50 Most Promising Israeli Startups Hit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts googletag.cmd.push(function() googletag.display('sopranos.1.ros.ctech'); );
Recommended videos
Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car Agritech Drone Startup Aerodrome Monitors Crops From the Sky googletag.cmd.push(function() googletag.display('big.box2.ros.ctech'); );
googletag.cmd.push(function() googletag.display('big.box1.ros.ctech'); );
googletag.cmd.push(function() googletag.display('big.box1.ros.ctech'); );
Recently Read
Saar Wilf’s Bid to Rid the World of Clunky Online Payments Calcalist’s 2018 List of 50 Most Promising Israeli Startups Hit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts Recently Read
Saar Wilf’s Bid to Rid the World of Clunky Online Payments Calcalist’s 2018 List of 50 Most Promising Israeli Startups Hit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts Recently Read
Saar Wilf’s Bid to Rid the World of Clunky Online Payments Calcalist’s 2018 List of 50 Most Promising Israeli Startups Hit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts googletag.cmd.push(function() googletag.display('sopranos.1.ros.ctech'); );
googletag.cmd.push(function() googletag.display('sopranos.1.ros.ctech'); );
Recommended videos
Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car Agritech Drone Startup Aerodrome Monitors Crops From the Sky Recommended videos
Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car Agritech Drone Startup Aerodrome Monitors Crops From the Sky Recommended videos
Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car Agritech Drone Startup Aerodrome Monitors Crops From the Sky googletag.cmd.push(function() googletag.display('big.box2.ros.ctech'); );
googletag.cmd.push(function() googletag.display('big.box2.ros.ctech'); );
googletag.cmd.push(function() googletag.display('special.prime.ros.ctech'); );
Twitter
Facebook
Newsletter
Contact Us
Rss
About CTech
Terms of Use
Privacy Policy
Developed by
UI & UX by Basch_Interactive
var axel = Math.random() + '';
var a = axel * 10000000000000;
document.write('
if (window.location.href.toLowerCase().indexOf('lobby')>-1)
document.querySelector('*[id^="prime."]').parentElement.removeChild(document.querySelector('*[id^="prime."]'));
document.getElementById('vilon').parentElement.removeChild(document.getElementById('vilon'));
document.getElementById('siteOverlay').parentElement.removeChild(document.getElementById('siteOverlay'));
Twitter
Facebook
Newsletter
Contact Us
Rss
About CTech
Terms of Use
Privacy Policy
Developed by
UI & UX by Basch_Interactive
var axel = Math.random() + '';
var a = axel * 10000000000000;
document.write('
if (window.location.href.toLowerCase().indexOf('lobby')>-1)
document.querySelector('*[id^="prime."]').parentElement.removeChild(document.querySelector('*[id^="prime."]'));
document.getElementById('vilon').parentElement.removeChild(document.getElementById('vilon'));
document.getElementById('siteOverlay').parentElement.removeChild(document.getElementById('siteOverlay'));
Twitter
Facebook
Newsletter
Contact Us
Rss
About CTech
Terms of Use
Privacy Policy
Developed by
UI & UX by Basch_Interactive
Twitter
Facebook
Newsletter
Contact Us
Rss
Twitter
Twitter
Twitter
Facebook
Facebook
Facebook
Newsletter
Newsletter
Newsletter
Contact Us
Contact Us
Contact Us
Rss
Rss
Rss
About CTech
Terms of Use
Privacy Policy
About CTech
Terms of Use
Privacy Policy
Developed by
UI & UX by Basch_Interactive
Clash Royale CLAN TAG#URR8PPP
